SCHEMBL2659765

SCHEMBL2659765

CCON(Cc1ccc(F)cc1)C(C)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.40
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
TRPA1 O75762 1/20 0.37
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 3/20 0.35
PYCR1 P32322 2/20 0.35
CA12 O43570 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
YAP1 P46937 1/20 0.34
TEAD4 Q15561 1/20 0.34
TEAD2 Q15562 1/20 0.34
MEN1 O00255 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
GAA P10253 1/20 0.33
POLB P06746 1/20 0.33
APEX1 P27695 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2659597 0.73 RIPK1 (0.44) RIPK1ALDH1A1KMT2APYCR1YAP1
SCHEMBL13153417 0.67 RIPK1 (0.44) RIPK1SLC6A2SLC6A4SLC6A3TRPA1
SCHEMBL2660021 0.66 MEN1 (0.47) SLC6A2SLC6A4SLC6A3ALDH1A1KMT2A
SCHEMBL16312137 0.64 PYCR1 (0.46) SLC6A2SLC6A4SLC6A3TRPA1ALDH1A1
SCHEMBL13181109 0.64 ALDH1A1 (0.46) RIPK1SLC6A2SLC6A4SLC6A3TRPA1
SCHEMBL13532083 0.63 PYCR1 (0.48) RIPK1SLC6A2SLC6A4SLC6A3TRPA1
SCHEMBL10294050 0.63 RIPK1 (0.50) RIPK1ALDH1A1PYCR1TDP1ESR1
SCHEMBL2660391 0.62 HRH4 (0.41) SLC6A2SLC6A4SLC6A3ALDH1A1KMT2A
SCHEMBL14350226 0.62 MCHR1 (0.42) RIPK1SLC6A2SLC6A4ALDH1A1KMT2A
SCHEMBL19598855 0.62 IDO1 (0.45) TRPA1ALDH1A1KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097557-A1 Cyanothiophene derivatives, compositions containing such compounds and methods of use DUFFY JOSEPH L (US) 2004-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097557-A1 Cyanothiophene derivatives, compositions containing such compounds and methods of use GLP1R, GPR119, GCGR RIPK1 1655/4885SLC6A2 771/4885SLC6A4 870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.